$Bilibili Inc.(BILI)$ Made a sweet little gain on BILI! Topped up my position with the Contra688 promo—free trading credits are just awesome. Bilibili's "high-quality growth" model is firing: thriving community, soaring profits/margins, plus hot new ads, AI music & games. Long way to go, holding for more gains!

$Advanced Micro Devices(AMD)$ 's downtrend reverses, rallying strong! Now targeting $250. Golden cross pattern with technical breakout—this rally's like a rocket, ready for takeoff!

$Baidu(BIDU)$ 's AI+ads combo shining! Ernie monetization + ad rebound = perfect timing. China tech sentiment recovering - holding through earnings season!

$BigBear.ai Holdings(BBAI)$ with modest gains - defense AI is an interesting play. With rising geopolitical tensions driving AI defense spending, the long-term thesis holds despite volatility.

$ProShares Ultra QQQ(QLD)$ 's Nasdaq leverage play is textbook perfect! Entering at 107.61 and exiting at 111.11, the $453.27 profit demonstrates how 2X ETFs optimally amplify tech rebounds. When market sentiment improves, these leveraged index products outperform individual stock picking by capturing sector-wide momentum while minimizing single-company risks - the smart money's go-to choice.

$C3.ai, Inc.(AI)$ has recently benefited from the overall strength of the technology sector, especially the market sentiment has warmed up due to the news that Trump postponed the 50% tariff on the European Union to July. At the same time, $NVIDIA(NVDA)$ is about to release its first quarter financial report, which also brings positive expectations to the entire AI and technology industry, driving up its stock price.

$ProShares Ether ETF(EETH)$ What a monster week for Bitcoin! It just posted its biggest single-week gain since the US election, outperforming the entire stock market! While gold and tech stocks are still figuring things out, BTC is already off to the races, carving its own independent path. For everyone still holding, this might just be the beginning of something wild!

$Direxion Daily S&P Biotech Bear 3x Shares(LABD)$ Anyone who has been in the biotech game long enough knows this sector is the wildest ride out there, no contest. It moves on its own terms, often out of sync with the broader market. I’ve always said that even within the Russell 2000, biotech is the ultimate hot money indicator, it either leads the charge or takes the first hit. On top of that, healthcare always carries a bit of a defensive edge. That’s why I played both sides with $Direxion Daily S&P Biotech Bull 3x Shares(LABU)$ and LABD. Looking at how things are shaping up now, I’d say that was a damn smart move. This win was mine to take!

$ProShares UltraShort Dow30(DXD)$ Adding more today! Taking advantage of the opportunity to buy in and see how it plays out.

$IONQ Inc.(IONQ)$ Just made a nice gain, and IONQ didn’t disappoint! This rising star in the quantum computing space has been shining lately! The company leverages ion-trap technology to enhance the stability and scalability of quantum computing, which is undeniably impressive. Here’s hoping it keeps up the momentum!

Oil up will more and more equate to alternatives and efficiencies. As people restrain the over use of a faulty product, with pollution and climate change etc, than the flooding of markets with oil to push demand up doesn't work, and slow the roll out of alternatives and efficiencies fails faster. One huge manipulating power for inflation thus loses their power. From wars around the globe by oil powers driving up debt and destruction, the world can't afford it or the climate change and pollution and living withing our means equates to inflation down and long term investing in America more viable/long bonds.With M2 trending down i look for this to aide the trend and friend as those dollars have to be used more wisely than the present J Biden/J Manchin policy of All of The Above almost as bad

Tough to decide whether or not to short this. I'm going to wait on 360 range then probably short in hopes for the santa claus rally to fade and money managers to move the meta stocks out of their portfolios.Few interviews with their software engineers and they said they were looking to monetize whatsapp by allowing businesses to do business on that app as a big potential money maker, and they still have a major focus on AI and double down on VR/AR metaverse.$META$ Bearish

Even if the Optimus 2 robots become available to work in its own factories in 2024, there is still WAY TOO MUCH DEMAND for the energy that the Tesla MEGAPACK batteries can provide for the robots to assemble and satisfy the need....not for YEARS, even though they are priced over $1,500,000 each and tens of thousands will be produced, with a lot of free labor.....by the ROBOTS annually. The new MegaPack factory in China will put out 10,000 MegaPacks per year, almost all used by China, and the GigaNevada MegaPack factory will be doubled in size to put out 20,000 units-per-year, again, at $1.5million each. That's 45 Billion bucks total revenue that Wall Street is ignoring as if it didn't exist....though they'll provide double the margins than the cars have.$TSLA$ Bullish

4. Before you start to panic and sell PYPL at this price, do your own research and think. So what are the facts about PYPL?1) y/y revenue UP by 7.1%, the number of transactions by 10.2%, total payment volume by 10.8%, EPS by 24.7%2) analysts' price targets after ER with one exception (see below) stay in the range $77 - $110 (I don't count one target $125 by Morgan Stanley as it's clearly unrealistic)3) the lowest price target ($65) was announced by an analyst named David Togut (Evercore), one of the worst ranked analysts with succes rate 50%. Moreover, on 9th July 21 this clown from Evercore raised the price target to $370 from $319, on 2nd Feb 22 he still recommends to BUY with PT $245, as he did in his last "analysis" form 1st Feb 23. And now this expert finally woke up.These "experts" s

The LTIP, currently as stated, the equivalent of 15 M shares have been awarded.  The new request is for another 15 M, or an equivalent total of 30 M shares in the fund.  We know those awards-to-date were and will be awarded at various valuations; for simplicity’s sake using today’s $8/sh valuation the pool’s cost to Shareholders conservatively would be +-$240M when fully awarded.  The first 15 M shares, since the plan’s inception 2018-2021 (2022 outstanding), estimated cost +- $120 M or $30 M per year on average ( the avg PPS during this period was +-$11 not $8).  Where did it go?  What was the headcount in those earlier years, certainly not +-40.  How much income did MARA generate during that period?  Hmmm, appears some accountability is in order. 

$Sidus Space Inc.(SIDU)$CAPE CANAVERAL, Fla. --(BUSINESS WIRE)-- Sidus Space, Inc . (NASDAQ:SIDU), a Space-as-a-Service satellite company focused on mission critical hardware manufacturing; multi-disciplinary engineering services; satellite design, production, launch planning, mission operations; and in-orbit support, is pleased to announce its growing relationship with Teledyne Marine, a part of Teledyne Technologies, Inc. (NYSE:TDY), following a noteworthy Q2 2022. The three-month period marks the strongest revenue quarter between the parties since their partnership began four years ago.

$Amazon.com(AMZN)$AMZN is rapidlyentering the healthcare sector, which was worth $808 billion in the U.S. alone last year, according to one estimate. I believe that, by 2030, Amazon could get 5%-10% of the total healthcare market by getting into the telehealth and prescription markets.Add in some overseas healthcare revenue, and we’re talking about a business that could easily generate $100 billion of annual revenue for AMZN within five years, moving the needle a great deal for the company and its shares.As I’ve noted in previous columns, I believe that Amazon’s new CEO, Andy Jassy, is much “hungrier” for success than his predecessor Jeff Bezos. Consequently, AMZN’s forays into businesses other than the cloud and e-commerce are far more likely to bea

$Amazon.com(AMZN)$AMZN is rapidlyentering the healthcare sector, which was worth $808 billion in the U.S. alone last year, according to one estimate. I believe that, by 2030, Amazon could get 5%-10% of the total healthcare market by getting into the telehealth and prescription markets.Add in some overseas healthcare revenue, and we’re talking about a business that could easily generate $100 billion of annual revenue for AMZN within five years, moving the needle a great deal for the company and its shares.As I’ve noted in previous columns, I believe that Amazon’s new CEO, Andy Jassy, is much “hungrier” for success than his predecessor Jeff Bezos. Consequently, AMZN’s forays into businesses other than the cloud and e-commerce are far more likely to bea